LIPOSORBER
LIPOSORBER
  • 21
  • 12 983
Pediatric FSGS and the Utility of Lipopheresis: CME Recording
Live CME Webinar recording with:
Katherine E. Twombley, MD
Hani M. Wadei, MD
Overview:
Focal Segmental Glomerulosclerosis (FSGS) in children is a difficult to treat kidney disease that can have devastating outcomes. Lipopheresis (LDL apheresis) is a type of apheresis that removes low-density lipoproteins (LDL) from the blood and is showing promise in treating pediatric patients with FSGS.
มุมมอง: 29

วีดีโอ

Familial Hypercholesterolemia (FH) Patient Journey: Exploring Treatment Options
มุมมอง 1914 วันที่ผ่านมา
This video will explain a typical Familial Hypercholesterolemia patient’s Journey and help you understand how it can affect you and your family, treatment options, and how LIPOSORBER apheresis therapy may help patients when diet and other drug therapies have failed.
LDL Cholesterol: How Low is too Low?
มุมมอง 92หลายเดือนก่อน
Dr. Benjamin J. Hirsh, Preventive Cardiologist at Northwell Health (NY) Dr. Robert D. Fishberg, Cardiologist, Atlantic Medical Group, Morristown Medical Center (NJ) The content for this session will: - Review the evidence, concerns, and lessons learned when treating very low levels of serum LDL cholesterol. - Recognize that specific subcategories of ASCVD risk are underlying the recent trends i...
Lp(a): Assessing and Treating a Major Source of Atherosclerosis - CME Recording
มุมมอง 3K5 หลายเดือนก่อน
Dr. Trippi and Dr. Brown give a short introduction of the current understanding of Lp(a) patho-physiology, a discussion of treatment options at present, a thorough discussion of how lipoprotein apheresis fits into the treatment landscape, two case histories of patients receiving lipoprotein apheresis for increased Lp(a) and a short discussion of medications in development for the treatment of L...
Mary N. - Familial hypercholesterolemia (FH) Patient Story
มุมมอง 2295 หลายเดือนก่อน
Mary N. tells her story about her FH and elevated Lp(a) diagnosis journey, explaining her family history of high cholesterol and cardiac events and the importance of getting tested and receiving the appropriate treatment.
Pediatric & Adult FSGS: When All Else Fails, Lipoprotein Apheresis? - CME Recording
มุมมอง 1516 หลายเดือนก่อน
Join Dr. Moritz and Dr. Mattiazzi as they discuss Focal segmental glomerulosclerosis, which fails to respond to steroids and calcineurin inhibitors and frequently progresses to ends stage kidney disease and can recur in the kidney transplant. Limited treatment options are available for the treatment resistant FSGS and recurrent FSGS in the transplant. Low-density lipoprotein apheresis has demon...
Lipoprotein Apheresis for Recurrent FSGS Patients in Post Kidney Transplant - CME Recording
มุมมอง 1246 หลายเดือนก่อน
Join Dr. Zaritsky and Dr. Voora as the discuss the epidemiology and clinical attributes of Focal Segmental Glomerulosclerosis (FSGS), poor results of available drug treatment options, and the mechanism and efficacy of lipid apheresis as a treatment for FSGS.
Lp(a): What We Should Know; Need to Know; and Hope to Know - CME
มุมมอง 3.5K9 หลายเดือนก่อน
Join Dr. Stephanie Saucier and Dr. Benjamin Hirsh as they discuss the role of lipoprotein(a) and its therapeutic options for patients with cardiovascular disease and review the science of Lp(a) and its role in the management and prevention of cardiovascular risk. Emerging therapeutics to reduce Lp(a) will be examined as well as how to apply currently available therapies. The material of this le...
Update on the management of elevated Lp(a) - CME
มุมมอง 2.6K10 หลายเดือนก่อน
Dr. Carranza Leon discusses the pathophysiology of lipoprotein(a) and its pro-atherogenic effects, appropriate testing of lipoprotein(a) levels, describes the current treatment paradigm for high-risk patients with elevated lipoprotein(a) and reviews treatment options.
Lpa: A Comprehensive Understanding of its Risk Factors, Burden, and Treatment Strategies - CME
มุมมอง 703ปีที่แล้ว
Dr. James Trippi and Dr. Michael Wilkinson shed light on the multifaceted aspects of Lp(a), including the risk factors, disease burden, and therapeutic interventions. The lecture aims to provide a comprehensive understanding of Lp(a), its significance in managing CVD risk, and available treatment options.
Advancement of FSGS Treatment and the Role of Lipoprotein Apheresis - CME Recording
มุมมอง 128ปีที่แล้ว
Nephrotic syndrome can be particularly challenging after renal transplantation. This is because the treatment of nephrotic syndrome involves immunosuppression which transplant patients already have received. FSGS is the most challenging of the nephrotic syndromes post-transplant. In this webinar, we will be discussing diagnosis and treatment strategies for recurrent FSGS after kidney transplant...
Lipoprotein Apheresis for Preventing Recurrence of FSGS after Kidney Transplantation
มุมมอง 104ปีที่แล้ว
Join Dr. Nicolae Leca (Medical Director, Kidney and Pancreas Transplant Program, Professor of Medicine/Nephrology, University of Washington Medical Center) and Dr. Tarek Alhamad (Associate Professor of Medicine, Medical Director of Transplant Nephrology, Division of Nephrology, Washington University in St. Louis) as they discuss the effect of hyperlipidemia on chronic progressive glomerular dis...
Lipid Apheresis for High-Risk Cardiovascular Patients
มุมมอง 249ปีที่แล้ว
Join Dr. Mintz (Director of Cardiovascular Health & Lipidology, President of the Northeast Lipid Association) and Dr. Gianos (Director of Women's Heart Health at Lenox Hill Hospital, Director of Cardiovascular Prevention for Northwell Health) as they discuss what defines a high-risk patient, the disease burden and underlying causes (FH, CAD, PAD, and stroke), what lipid apheresis is and how it ...
Using Lipoprotein Apheresis for Preventing Recurrence of FSGS Post Kidney Transplant - CME Recording
มุมมอง 113ปีที่แล้ว
Dr. Zaritsky, Pediatric Nephrologist at Ascension Sacred Heart Hospital, UF Health and Phoenix Children's Hospital, and Dr. Amir Abdi Pour, Division of Nephrology, Department of Medicine at Loma Linda University Health School of Medicine, discuss the use of Low-Density Lipoprotein Apheresis for the prevention of Focal Segmental Glomerulosclerosis (FSGS) after kidney transplantation.
Focal Segmental Glomerulosclerosis: Management of Complex Patients - CME Recording
มุมมอง 108ปีที่แล้ว
Join Dr. Abdallah Geara and Dr. Michael Moritz as they discuss management of FSGS in complex patients, including some specific case studies.
Lp(a): A Challenge in Diagnosis and Treatments - CME Recording
มุมมอง 173ปีที่แล้ว
Lp(a): A Challenge in Diagnosis and Treatments - CME Recording
Treating recurrent FSGS in post kidney transplant patients - CME Recording
มุมมอง 371ปีที่แล้ว
Treating recurrent FSGS in post kidney transplant patients - CME Recording
Lipoprotein Apheresis as a treatment option for FH and Lp(a) patients - CME Recording
มุมมอง 213ปีที่แล้ว
Lipoprotein Apheresis as a treatment option for FH and Lp(a) patients - CME Recording
Utility and Feasibility of LDL-Apheresis in Pediatric FSGS Patients - CME Recording
มุมมอง 79ปีที่แล้ว
Utility and Feasibility of LDL-Apheresis in Pediatric FSGS Patients - CME Recording
Kaneka LIPOSORBER Training Video
มุมมอง 848ปีที่แล้ว
Kaneka LIPOSORBER Training Video
How the LIPOSORBER® System works
มุมมอง 192ปีที่แล้ว
How the LIPOSORBER® System works

ความคิดเห็น

  • @pininfarinarossa8112
    @pininfarinarossa8112 9 วันที่ผ่านมา

    In Europe/ Germany statins are prescribed and they wait for ME as well.😮

  • @luckssj
    @luckssj 18 วันที่ผ่านมา

    How about Magnesium Glycinate and Liposomal Vitamin C at dosage above 10 grams per day? Works for me - no drugs.

  • @jaqueitch
    @jaqueitch หลายเดือนก่อน

    SLN360 is now entering Phase 3! SLN360 showed up ton99% knockdown of LP(a) expression in the Phase 2 trial!! 👌👌👌

  • @optimalhealthmedicine1486
    @optimalhealthmedicine1486 หลายเดือนก่อน

    Testosterone with its natural conversion to 17b estradiol lowers the Lp(a) in our youth and with weekly optimal doses. * Look up 17b estradiol and lower Lp(a). (NOT estrogen which is pregnant mare urine estrogen Premarin) *17b estradiol elevating HDL cholesterol *17b estradiol lowering fibrinogen THIS is nothing new to those of us in the Bioidentical hormone specialty!! Big Pharma does NOT want you to know this because they can’t patent testosterone or oral 17b estradiol!!

  • @941charna
    @941charna หลายเดือนก่อน

    I’m pretty shocked at the treatment decisions these two doctors are choosing - they treat LDLs and try to get results below 70 and they say that statin treatment can elevate LPa which causes increased risk of ASCD BUT they don’t check after initiating statin therapy because they don’t want to make their patients nervous because their therapy is elevating the LPa - to me it is recipe for malpractice - except it probably is the standard of care. How disturbing!

    • @jaqueitch
      @jaqueitch หลายเดือนก่อน

      No no no. They're being cautious about eliminating LDL therapy in favor of minimal interventions available for LP(a). Once the LP(a) therapies are available in ~2026, we might see less focus on LDL. That said, you would need to have head-to-headbstudies for LP(a) therapy with and without LDL drugs, once the LP(a) drugs are available.

  • @941charna
    @941charna หลายเดือนก่อน

    Were you taking statins to lower your LDLs - I thought I saw that statins can raise LPa

    • @jaqueitch
      @jaqueitch หลายเดือนก่อน

      Yes, statins can raise LP(a). The thinking around LDL levels is changing. Cholesterol is critical to your body functioning properly.

  • @terryelizabeth2841
    @terryelizabeth2841 2 หลายเดือนก่อน

    I don’t understand the rationale of waiting until a person has shown dangerous signs of the development of CVD to start looking for a major risk factor in the development of CVD. I guess the European position of testing lp(a) on everyone makes more sense to me. Especially if you consider that lp(a) represents a risk factor that is cumulative from childhood.

  • @michaelhimes8778
    @michaelhimes8778 4 หลายเดือนก่อน

    I’ve known about my high Lp(a) for about a year and a half. Age 49, I have never had an event and was referred for PVCs. Because I’m youngish, fit, and had a zero CAC, my cardiologist is just having me wait… wanted to see me in 3 years. With the push to get this out there now, the reality of how serious this is is setting in. It looks like the current state is to just get as healthy as possible and wait for the first heart attack if insurance is to cover anything. Very depressing.

  • @HendrikRitsema
    @HendrikRitsema 4 หลายเดือนก่อน

    Best treatment for atherosclerosis: Vitamin C Why do only coronary arteries clog with cholesterol and not veins or small capillaries? Scurvy = No vitamin C in your diet. Symptom: Your blood vessels break and you bleed to death. Think of the sailor of the past. Scurvy of the heart = Just enough vitamin C from food. Symptom: Arteries around the heart are not strong enough to resist high blood pressure. Damage is repaired with cholesterol LP(a) to prevent worse. After years of repair, your arteries become clogged. Enough vitamin C supplement of at least 3000 mg. per day gives strong and flexible arteries. Cholesterol is not needed as a repair agent. Cholesterol in your coronary arteries is broken down and burned in your liver. Source TH-cam: Cardiovascular disease and vitamin C (Dr. Rath Foundation) or Breakthrough Towards The Natural Control Of Cardiovascular Disease - Dr. Rath's 2018 Cyprus Lecture

  • @dustinirwin1
    @dustinirwin1 4 หลายเดือนก่อน

    Interesting - but pls start with the bottom line up front. A complex case study with no clear direction of where we are going puts a huge burden on the audience to synthesize all of this, somewhat aimlessly.

  • @Youtubedisco
    @Youtubedisco 4 หลายเดือนก่อน

    LPa is 31 nmol. I eat all animal products, minimal nuts, vegetables. IT'S THE CARBS AND SUGAR. I'm a 63-year old female. No meds. I do take Hormone replacement therapy.

  • @Youtubedisco
    @Youtubedisco 4 หลายเดือนก่อน

    Low carb is the only answer. Zero added sugar-zero problems. I'm 63, no meds. LPa 31 NMOL. VLDL 16 mg, triglycerides 93, HDL 71, LDL 179. 266 total cholesterol. Ratios excellent. CAC is Zero. CIMT all clear. Heart MRI excellent. No plaque, no inflammation. It's not an enigma! It's added sugars/refined carbs.

  • @monnoo8221
    @monnoo8221 5 หลายเดือนก่อน

    Lp(a) is NOT a cause of athersclerosis. It is best a mediator, s it prevents clots from being dissolved. point i, one has to avoid injuries of endothelium in the first place. Prevent high glucose, prevent inflammation, eat low carb to elevate HDL = preventing the breakdown through triglycerides, keep hmocystein in check via folate B12 and betaine.... Secondly, ordinary vit C is strongly inversely correlated with Lp(a). you are wasting 1h+ of time

    • @JMK-vo8pv
      @JMK-vo8pv 4 หลายเดือนก่อน

      You nailed it, monnoo! There is ABSOLUTELY ZERO PROOF in any study, any research, any literature that Lp(a) particles actually CAUSE atherosclerosis. The only thing that the Lp(a) zealots have to keep pushing their bogus theory on Lp(a) is a bunch of ASSOCIATIONAL data that proves nothing. As the well respected cardiologist, Dr. Nadir Ali says, "Lp(a), just like LDL, is a 'firefighter' and has nothing to do with CAUSING atherosclerosis/plaque". Dr. Nadir Ali reports that he has performed coronary angiograms on some elderly people with lifelong elevated Lp(a) levels and these senior citizens have perfectly clean coronary arteries!

  • @luckssj
    @luckssj 5 หลายเดือนก่อน

    Have you looked at Vitamin C as a great method for lowering Lpa?

  • @TimmieTennis
    @TimmieTennis 5 หลายเดือนก่อน

    How would you treat TC: 240, LDL: 157, TG:65, HDL: 68, LP(a): 81, apoB: 105? Thx, Tim

  • @Spicydoc1
    @Spicydoc1 5 หลายเดือนก่อน

    What a contradiction she speaks of. Nelson has a 21% reduction in lipoprotein a and the other PCSK9 inhibitor reduces leopard protein by 20 to 30%. So they both do the same thing practically this is clearly and undoubtedly pharm bias.

  • @Spicydoc1
    @Spicydoc1 5 หลายเดือนก่อน

    I’ve been watching other channels, and there is a dietary modification with the use of high doses of vitamin C, amino acids proline, and lysine called the Pauling protocol. Looked that up. I’m also interested in that.

  • @davidmusial1611
    @davidmusial1611 5 หลายเดือนก่อน

    High dose lysine lowers lp(a)

    • @e8a284
      @e8a284 5 หลายเดือนก่อน

      And vitamin c?

    • @WhereNerdyisCool
      @WhereNerdyisCool 5 หลายเดือนก่อน

      Interesting to know. I have high Lp(a) and take Repatha and a daily Lysine supplement.

    • @MrFavor09
      @MrFavor09 5 หลายเดือนก่อน

      how much lysine?

  • @davidmusial1611
    @davidmusial1611 5 หลายเดือนก่อน

    The chart doesn't say how much niacin was used. This is typical md bs.

  • @beepbeepnj2658
    @beepbeepnj2658 5 หลายเดือนก่อน

    Lp(a) is in your genetics to live a long healthy life. "Remarkably, one-quarter of the centenarians had high Lp(a) serum levels even though they never suffered from atherosclerosis-related diseases." 1998 G. Baggio. Low levels of Lipoprotein(a) are not good. 2012 article title: Low Lipoprotein(a) Concentration Is Associated with Cancer and All-Cause Deaths: A Population-Based Cohort Study (The JMS Cohort Study) The Lp(a) levels were inversely correlated with the CIMT in this population, suggesting that subjects with a low Lp(a) level may have a predisposition to carotid atherosclerosis. This finding was preliminary and should be investigated further in larger studies and in additional settings. 2012 article title, CIMT thickness in asymptomatic subjects with low Lipoprotein(a) levels.

    • @user-wf2ho3kd9n
      @user-wf2ho3kd9n 5 หลายเดือนก่อน

      I am 79 and no event but LPa 217 and never knew about it until 2 years ago but have been put on 5mgs Crestor and 10 mgs Zetia plus a 81 mgs aspirin daily. I feel fine and fast 18 hours a day and eat low carb/ Mediterranean. I am 5’5” and 128. All blood tests are great except LDL was 152 but now 80. APOB 80 and HDL 116 and Triglycerides 63 all prior to starting meds.

    • @HuyLe-up3mx
      @HuyLe-up3mx 4 หลายเดือนก่อน

      @@user-wf2ho3kd9n Thanks for sharing Goes to show that lifestyle is very important

  • @luckssj
    @luckssj 5 หลายเดือนก่อน

    How about Triglycerides over HDL and give her D3 and K2-MK7 and Nattokinase and Nitric Oxide?

  • @richards4422
    @richards4422 5 หลายเดือนก่อน

    If aspirin might be beneficial for pt's with elevated Lp(a), would a true anticoagulant possibly be even better ?

  • @milanpintar
    @milanpintar 5 หลายเดือนก่อน

    so complicated and poor aerospace engineer

  • @gotem1725
    @gotem1725 5 หลายเดือนก่อน

    Thoughts on saturated fats lowering lp (a) and polyunsaturated fats increasing lp (a)?

  • @GasMart623
    @GasMart623 5 หลายเดือนก่อน

    If a person with higher LPa gives blood regularly, would this be a way to get Apheresis?

    • @ezzovonachalm9815
      @ezzovonachalm9815 5 หลายเดือนก่อน

      ...to poison the unfortunate blood recipient ? We already have problems with covid-19 vaccinated patients with elevated circulating Spike Protein !

  • @michael-qp9xd
    @michael-qp9xd 5 หลายเดือนก่อน

    Hello - i read study paper from 10 plus yrs ago indicating significant reduction of lpa with oral l-carnitine supplementation. And slight reduction with 40mg daily flax seed. Any more can add to this with maybe newer studies or newer thinking on exactly why these of true benefit?

  • @wasteoftimeacc1
    @wasteoftimeacc1 6 หลายเดือนก่อน

    ❤sixteen.zDy67\,¥’&.&, two Kx cc if.6-,%5. K I faced Cajun was c8?😮🎉Us

  • @jon0604
    @jon0604 7 หลายเดือนก่อน

    Let’s see if I have this right. Statins didn’t do a thing for this patient ( because they actually don’t work since LDL-C is just a marker for metabolic disfunction), and LP(a) is the better predictor but don’t give niacin to reduce LP(a) even though you showed that a lower level of LP(a) worked and instead go ever lower with LDL lowering by adding PCSk9 inhibitors? Hmmm

  • @cybermillers
    @cybermillers 8 หลายเดือนก่อน

    Excellent update, thank you!

  • @marinasaif2306
    @marinasaif2306 8 หลายเดือนก่อน

    excellent lecture ,Thank YOU so much

  • @plants_and_wellness1574
    @plants_and_wellness1574 8 หลายเดือนก่อน

    My Lp(a) was 246 nmol/L in June of last year, by September it was 293 nmol/L, and got it checked again in April because it was part of a package I bought and it came back at 380 nmol/L. So, in one year my Lp(a) went from 246 to 380 🙃 it was lower when I was eating lots of meat and butter and higher now that I am plantbased…on the other hand my particle count has come DOWN exponentially as well as my LDL-small particles. My LDL is actually higher now though and I don’t know why 😢 it was 117 last June and now it’s 132.

    • @Kjuken69
      @Kjuken69 3 หลายเดือนก่อน

      Who CARES? the last thing you should worry about is LDL!

  • @grantingapex8169
    @grantingapex8169 8 หลายเดือนก่อน

    thank you. fabulous presentation

  • @May_Day45
    @May_Day45 9 หลายเดือนก่อน

    Is it just me, or have these lipoproteins(a) and other heart issues suddenly started to come to the surface? 🤔

    • @themekfrommars
      @themekfrommars 7 หลายเดือนก่อน

      I think it's because the tests have become easily available and cheap

    • @theMDMentor
      @theMDMentor 5 หลายเดือนก่อน

      Yes, and new astronomically priced treatments....@@themekfrommars

    • @jaqueitch
      @jaqueitch หลายเดือนก่อน

      LP(a) finally has some therapies for addressing the issue in Phase 2/3 studies

  • @dalialovesdoggies4361
    @dalialovesdoggies4361 ปีที่แล้ว

    How about Apo B please?

  • @dalialovesdoggies4361
    @dalialovesdoggies4361 ปีที่แล้ว

    Totally scary